Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-25-004528
Filing Date
2025-02-03
Accepted
2025-02-03 06:24:35
Documents
83

Document Format Files

Seq Description Document Type Size
1 form424b4.htm   iXBRL 424B4 3002451
  Complete submission text file 0001493152-25-004528.txt   11897523

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20240930.xsd EX-101.SCH 81531
3 XBRL CALCULATION FILE envb-20240930_cal.xml EX-101.CAL 81921
4 XBRL DEFINITION FILE envb-20240930_def.xml EX-101.DEF 312377
5 XBRL LABEL FILE envb-20240930_lab.xml EX-101.LAB 629051
6 XBRL PRESENTATION FILE envb-20240930_pre.xml EX-101.PRE 485110
85 EXTRACTED XBRL INSTANCE DOCUMENT form424b4_htm.xml XML 2064773
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-284277 | Film No.: 25580500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)